𝔖 Bobbio Scriptorium
✦   LIBER   ✦

p53 and the malignant progression of Barrett's esophagus

✍ Scribed by Elettra Merola; Pier Paolo Claudio; Antonio Giordano


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
110 KB
Volume
206
Category
Article
ISSN
0021-9541

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Barrett's esophagus (BE) is a metaplastic disorder in which specialized columnar epithelium replaces healthy squamous epithelium (intestinal metaplasia). Even though its pathophysiology and the steps of its neoplastic progression are not completely understood, BE can be considered as a complication of gastroesophageal reflux disease (GERD). Given that esophageal adenocarcinoma, which is continually increasing in the Western world, still has a poor prognosis and suffers from late diagnosis, and because BE is a precancerous lesion, there is a strong need for good molecular markers of malignant progression in Barrett's metaplasia (BM). The aim of this review is to examine the published data regarding the role that assessment of p53 may play in the management of BE, trying to understand if it may be a useful marker to early diagnose BE malignant transformation. Β© 2005 Wiley‐Liss, Inc.


πŸ“œ SIMILAR VOLUMES


hERG1 channels in human esophagus: Evide
✍ Elena Lastraioli; Antonio Taddei; Luca Messerini; Camilla E. Comin; Mara Festini πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 417 KB

## Abstract Ion channels regulate a broad range of cellular activities. Alteration in ion channel function has been reported in different human pathologies, such as cardiac, neuromuscular, autoimmune diseases, and cancer. We investigated the expression of hERG1 K^+^ channels in the human upper gast

Expression of the cyclin-dependent kinas
✍ Jay S. Hanas; Megan R. Lerner; Stan A. Lightfoot; Carl Raczkowski; Donald J. Kas πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 700 KB

BACKGROUND. Barrett esophagus predisposes individuals to esophageal carcinoma, which develops from intermediate stages of tissue dysplasia primarily in the vicinity of the gastroesophageal junction. Understanding the cellular and molecular events in the progression of Barrett esophagus to adenocarci

Inducible nitric oxide synthase, nitroty
✍ Nadine M. Vaninetti; Laurette Geldenhuys; Geoffrey A. Porter; Harvey Risch; Pier πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 154 KB

## Abstract Nitric oxide (NO) has been implicated as a potential causative factor for endogenous p53 mutations in gastrointestinal malignancy. To investigate the role of NO in esophageal adenocarcinoma (EADC), we studied patterns of p53 mutations, expression of inducible nitric oxide synthase (iNOS